MWNA
GBIO

Marshall Wace North America’s Generation Bio GBIO Stock Holding History

Marshall Wace North America’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$11.3M Buy
44,879
+39,824
+788% +$9.54M 0.05% 331
2021
Q2 		$1.36M Buy
+5,055
New +$1.51M 0.01% 927
2020
Q3 		– Sell
-4,578
Closed -$961K – 1303
2020
Q2 		$961K Buy
+4,578
New +$1.02M 0.01% 767

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Marshall Wace North America's GBIO Position: Q3 2021 in Review

Marshall Wace North America increased its Generation Bio (GBIO) stake by 788% in Q3 2021, buying an estimated $9.54M and bringing the position to 44,879 shares worth $11.3M. The position accounts for 0.05% of the portfolio, ranked #331.

Marshall Wace North America first reported a position in GBIO in Q2 2020 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold GBIO as of Q3 2021.

  • Marshall Wace North America held 44,879 shares of Generation Bio worth $11.3M as of Q3 2021.
  • Marshall Wace North America bought 39,824 Generation Bio shares in Q3 2021, an estimated $9.54M.
  • Generation Bio made up 0.05% of Marshall Wace North America's portfolio in Q3 2021, its #331 holding.
  • Marshall Wace North America first reported a position in Generation Bio in Q2 2020 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held Generation Bio as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.